IMMX

Immix Biopharma, Inc. · Healthcare

Insider Buying

$10K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Latest filing

May 29, 2026

Morris Gabriel S

Immix Biopharma, Inc. (IMMX) has 9 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: May 29, 2026.

Inside the rolling window, 2 insiders at Immix Biopharma, Inc. reported 2 open-market purchases totaling $10K and no open-market sales. The most recent open-market filing is a purchase of 770 shares by CFO Morris Gabriel S, dated Dec 10, 2025, worth $5K.

  • Industry:Biotechnology
  • CEO:Ilya Rachman
  • Employees:21
  • HQ:Los Angeles, CA, US
  • IPO:2021-12-16
Source
Morris Gabriel SFirst filing
Purchase$5KDec 10SEC ↗
Rachman Ilya MFirst filing
Purchase$5KDec 10SEC ↗
Showing 1–2 of 2
1 / 1

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does IMMX have?

Immix Biopharma, Inc. (IMMX) has 9 SEC Form 4 filings (9 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: May 29, 2026.

When was the most recent SEC Form 4 filing for IMMX?

The most recent Form 4 filing for IMMX on Tracefour is dated May 29, 2026.

What is the net insider flow at IMMX over the last 6 months?

Over the trailing 180 days, insiders at IMMX have net bought $10K based on SEC Form 4 disclosures.

What is the total insider buy and sell value at IMMX in the current window?

Inside the rolling window, insiders at IMMX bought $10K and sold $0 based on SEC Form 4 filings.

Can I get alerts for IMMX insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Immix Biopharma, Inc. (IMMX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Immix Biopharma, Inc. is in the Healthcare sector.